The WOCN Society 40th Annual Conference (June 21-25th, 2008)


2207

Leg ulcers presenting a major risk of secondary infection, as seen in outpatient care. Advantages of an absorbent dressing impregnated with silver salts*

Manuel Alves, MD, Clinique du Parc, Vascular Medicine Specialist, 4, avenue du Morvan, Lyon, F-71400, France, Benoit Chapelon, MD, Cabinet d'Angiologie, Vascular Medicine Specialist, 3, rue du Palais, 71600 Paray-le-Monial, France, Patricia Senet, MD, Pavillon l'Orbe, Chef de Service Geriatrie, 7 avenue de la Republique, 94205 IVRY SUR SEINE, France, Hugues Cartier, MD, Cabinet de Dermatologies, Vascular Medicine Specialist, 7, Square St. Jean, 62000 Arras, France, and Serge Bohbot, MD, Laboratoires URGO, Medical Director, 49, rue Longvic, 21300 Chenove, France.

Introduction: Although it has been widely demonstrated that chronic wounds, particularly leg ulcers, are colonized by pathogenic bacterial flora, it is not considered pertinent to use antibacterial agents systematically during topical care operations. However, the onset of local clinical signs (perilesional inflammation, pain between two dressing changes, malodorous wound, abundant exudate, etc.) combined with a failure to show any improvement, may raise the risk of a local secondary infection. Under these conditions, some recommend using an antibacterial agent.

Methods: We report here our initial experiences of a new absorbent dressing impregnated with silver salts*.

 Results: When this dressing was used on leg ulcers presenting clinical signs of "critical colonization", it was conducive to re-establishing a favorable healing process within a few weeks and substantially reduced clinical signs (namely the appearance of perilesional skin) and the malodorous nature of the wound from the first few days of application.

 Conclusions: The authors describe the regular clinical, photographic and planimetric follow-up of these wounds by means of a 3 clinical cases.

These results demonstrate the efficacy of the new foam dressing with silver* for wounds presenting a major risk of local secondary infection and must now be supported by a clinical evaluation in a larger patient cohort.